Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.58

+1.8%

Nov 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1934)	10/4/2007 11:38:19 AM
From: Jibacoa	Read Replies (2) of 3722

NEOL Has been forming a base at the $0.92 level & looking at the volumes,all the increases have coincided with the "spikes".<g> bigcharts.marketwatch.com NEOL Has been trimming its losses consistently for the past 4Qs & the EL for 2007 is around $0.60/shr vs $1.14/shr in 2006 Last month it announced the appointment of Dr. Shahid Ali to V.P., Research & Development,planning on developing NEOL's drug portfolio,with focus on: Its NeoLipid platform;advancing Cintredekin Besudotox for the treatment of pulmonary fibrosis and asthma & completing the review of the drug program for indication of recurrent GBM NEOL doesn't have significant LTD. The insiders hold around 20%.The stock needs to close above the $1.20 level before it can test the more important resistance at the $1.50 to $1.60 level, but the R/R doesn't look bad at present levels.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next